FIGO STAGE IV OVARIAN CANCER 2014
Clinical trials for FIGO STAGE IV OVARIAN CANCER 2014 explained in plain language.
Never miss a new study
Get alerted when new FIGO STAGE IV OVARIAN CANCER 2014 trials appear
Sign up with your email to follow new studies for FIGO STAGE IV OVARIAN CANCER 2014, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter maintenance therapy may be just as effective for BRCA-Linked ovarian cancer
Disease control Recruiting nowThis phase 3 trial tests whether taking the drug olaparib for one year works as well as taking it for two years to keep ovarian cancer from coming back. The study includes 880 people with advanced ovarian cancer (stage III or IV) who have a BRCA mutation or similar DNA repair pro…
Matched conditions: FIGO STAGE IV OVARIAN CANCER 2014
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New vaccine aims to outsmart ovarian cancer recurrence
Disease control Recruiting nowThis phase II trial tests whether a custom-made vaccine (FRαDCs) can help prevent or delay cancer from coming back in people with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The vaccine is made from a patient's own white blood cells and trained to targe…
Matched conditions: FIGO STAGE IV OVARIAN CANCER 2014
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC